Kantoff Philip W.
Transaction: 06/24/2026
BUY
Change
+45,000
Price
$0.58
Filing
06/26/2026
Type
BUY
Context Therapeutics Inc.
CNTX • Biotechnology
$0.36
▼ -0.00 (-0.36%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$34.43M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 8.52Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.36
Change-0.36%
Shares Out95.18M
Market Cap$34.43M
Enterprise Value$-19.82M
52W Range0.55 - 3.62
Beta1.61
P/E-0.86
P/B0.66
P/FCF-0.99
EV/EBITDA0.47
EV/FCF0.57
Price$0.36
Change-0.36%
Shares Out95.18M
Market Cap$34.43M
Enterprise Value$-19.82M
52W Range0.55 - 3.62
Beta1.61
P/E-0.86
P/B0.66
P/FCF-0.99
EV/EBITDA0.47
EV/FCF0.57
Earnings Yield-116.84%
FCF Yield-101.15%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio8.52
Quick Ratio8.52
Target$5.25
Target Upside1351.48%
Target Median$5.25
Target Range4.50 - 6.00
Volume14.82M
Avg Volume1.70M
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 8.52Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-09-05
100/100
Bullish
Bullish
6
Hold
0
Bearish
0
Price Target
2026-06-29
Low
$4.50
Mean
$5.25
Median
$5.25
High
$6.00
Insider Transactions
Recent executive and insider activity
Walker Luke Nathaniel
Transaction: 06/24/2026
BUY
Change
+45,000
Price
$0.58
Filing
06/26/2026
Type
BUY
Smith Karen L.
Transaction: 06/24/2026
BUY
Change
+45,000
Price
$0.58
Filing
06/26/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kantoff Philip W. | BUY | +45,000 | $0.58 | 06/24/2026 | 06/26/2026 |
| Walker Luke Nathaniel | BUY | +45,000 | $0.58 | 06/24/2026 | 06/26/2026 |
| Smith Karen L. | BUY | +45,000 | $0.58 | 06/24/2026 | 06/26/2026 |
| West Linda | BUY | +45,000 | $0.58 | 06/24/2026 | 06/26/2026 |
| Stacey Jennifer Evans | BUY | +45,000 | $0.58 | 06/24/2026 | 06/26/2026 |
| Pasternak Andy | BUY | +45,000 | $0.58 | 06/24/2026 | 06/26/2026 |
| Lehr Martin A. | BUY | +815,000 | $2.32 | 02/19/2026 | 02/23/2026 |
| Chagin Karen Deborah | BUY | +290,000 | $2.32 | 02/19/2026 | 02/23/2026 |
| Minai-Azary Jennifer Lynn | BUY | +275,000 | $2.32 | 02/19/2026 | 02/23/2026 |
| Levit Alex C. | BUY | +270,000 | $2.32 | 02/19/2026 | 02/23/2026 |
| West Linda | BUY | +123,500 | $0.65 | 06/12/2025 | 06/12/2025 |
| Walker Luke Nathaniel | BUY | +123,500 | $0.65 | 06/12/2025 | 06/12/2025 |
| Stacey Jennifer Evans | BUY | +123,500 | $0.65 | 06/12/2025 | 06/12/2025 |
| Smith Karen L. | BUY | +123,500 | $0.65 | 06/12/2025 | 06/12/2025 |
| Kantoff Philip W. | BUY | +123,500 | $0.65 | 06/12/2025 | 06/12/2025 |
| Pasternak Andy | BUY | +138,900 | $0.65 | 06/12/2025 | 06/12/2025 |
| Lehr Martin A. | BUY | +100,000 | $0.70 | 06/09/2025 | 06/10/2025 |
| Minai-Azary Jennifer Lynn | BUY | +40,010 | $0.64 | 06/06/2025 | 06/10/2025 |
| Levit Alex C. | BUY | +20,000 | $0.58 | 06/06/2025 | 06/10/2025 |
| Chagin Karen Deborah | OTHER | 0 | Not reported | 06/09/2025 | 06/09/2025 |